AzTrials
AzTrials

AppetiteNCT05534152

Effect of Sumac on Appetite and Food Intake

A study testing sumac in people with Appetite and Food Intake, run by Oxford Brookes University at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Sumac, is a spice that is widely used in Turkish, Iranian and Middle Eastern foods. In these regions, the fruit of sumac is used for seasoning or flavouring, as an appetizer and for souring food. Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Appetite, Food Intake
What is being tested?
sumac
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
40 participants
Where
1 siteUnited Kingdom
Study dates
1 Nov 2018to 15 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • • Adults, aged >65 years
  • Adults, 18-35 years
  • No allergy to any herbs and spices
  • No allergy to vegetables including celery and tomato
  • Non-smoker
  • Do not have a cold or hay fever (on test day)
Show all 11Show fewer
  • No medication that may affect the sensory taste such as: antibiotics, antihistamines and decongestants, anti-inflammatory agents, and muscle relaxants (Bromley, 2000)
  • Ability to read and understand written information in English
  • Ability to attend, stand and sit for up to one hour
  • The normal level of capability of functional activity (i.e. traveling out to the neighbourhood, shopping alone)
  • Not diagnosed with Dementia

Who cannot join

  • Disease that may affect the taste and smell sensation including local chronic or acute inflammatory nasal disease and oral and perioral infections

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Oxford Brookes Centre for Nutrition and Health

    Oxford, OX3 0BP

Other trials in United Kingdom

About this study

Official title: The Effect of Consumption of Sumac in Vegetable Soup on Appetite and Food Intake Among Older Adults (Aged Over 65 Years) and Young Adults (Aged 18-35 Years)

Sumac, is a spice that is widely used in Turkish, Iranian and Middle Eastern foods. In these regions, the fruit of sumac is used for seasoning or flavouring, as an appetizer and for souring food. This spice has also been used in herbal folk medicine to relieve certain conditions including bowel disorders, anorexia and indigestion. In addition, many studies have shown that sumac contains a high level of antioxidant activity and polyphenol content that may benefit certain diseases such as cancer and diabetes. The aim of this study was to assess the level of the appetite and food intake among young adults in comparison with free living older adults following the consumption of sumac. This was achieved by assessing the amount of food intake during a lunch course and the impact on food intake for the subsequent 12 hours.

Read the detailed description

Rhus coriaria Linn, also known as Sumac, is a spice that is widely used in Turkish, Iranian and Middle Eastern foods. In these regions, the fruit of sumac is used for seasoning or flavouring, as an appetizer and for souring food. This spice has also been used in herbal folk medicine to relieve certain conditions including bowel disorders, anorexia and indigestion. In addition, many studies have shown that sumac contains a high level of antioxidant activity and polyphenol content that may benefit certain diseases such as cancer and diabetes.

Taste and smell perception may play a vital role in food preference, nutrient intake and appetite; however, both ageing and disease can have a negative impact on these senses. It has been suggested that by 2025 the older adult population (i.e. those aged 60years and over) worldwide will rapidly increase and reach 1.12 billion. One of the major physiological changes in this age group is the loss or reduction in sensory perception including smell and taste. These changes as a result of ageing and medication increase the risk of poor health by reducing the enjoyment of food followed by decreasing food and nutrient intake.

It is possible, therefore, that all these factors together may lessen the enjoyment of food, leading to malnutrition and disease complications. In light of the above, the aim of this study was to assess the level of the appetite and food intake among young adults in comparison with free living older adults following the consumption of sumac. This was achieved by assessing the amount of food intake during a lunch course and the impact on food intake for the subsequent 12 hours.

This study assessed the use of sumac at 1% dose (0.37g) of total volume of a vegetable soup (150g), in two forms: 1) added to finished cooked soup 2) added to the soup from the beginning of the cooking process, in addition to consumption of the same soup without added sumac as the control soup. The study comprised of 20 young adults (18-35 years old) and 20 free living older adults aged >65 years. Each participant in these groups attended the Oxford Brookes Centre for Nutrition and Health (OxBCNH) for three sessions and each session lasted up to one hour.

Being tested
sumac

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • sumacOther

    1% iranian brown sumac

Study groups in NCT05534152
Study groupRoleWhat they receive
Soup with no sumacPlacebo comparator150 g butternut squash soup with no added sumac
Receives: Other: sumac
Sumac added to soup at the end of cookingExperimental150 g butternut squash soup with 1% sumac added at the end of cooking
Receives: Other: sumac
Sumac added to the sumac during cookingExperimental150 g butternut squash soup with 1% sumac added during cooking
Receives: Other: sumac

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Energy intake in kilojoules and kilocalories

    Energy intake at an ad libitum lunch after the soup and for the rest of the day using Nutritics dietary assessment software.

    Measured: 9 hours

  2. Carbohydrate intake in grams

    Carbohydrate intake at an ad libitum lunch after the soup and for the rest of the day using Nutritics dietary assessment software.

    Measured: 9 hours

  3. Protein intake in grams

    Protein intake at an ad libitum lunch after the soup and for the rest of the day using Nutritics dietary assessment software.

    Measured: 9 hours

  4. Fat intake in grams

    Fat intake at an ad libitum lunch after the soup and for the rest of the day using Nutritics dietary assessment software.

    Measured: 9 hours

  5. Amount of food consumed at lunch in grams

    Amount of food (pasta) consumed in grams at the ad libitum lunch

    Measured: 9 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Sep 2022
  2. Study start1 Nov 2018
  3. Primary completion28 Feb 2020
  4. Study completion15 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05534152
Sponsor's protocol ID
UREC 181174
Status last verified
Sep 2023
First submitted
31 Jul 2022
Last updated
6 Sep 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing sumac in people with Appetite and Food Intake, run by Oxford Brookes University at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Energy intake in kilojoules and kilocalories (time frame: 9 hours). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in